This bill proposes significant updates to the current statutes regarding the administration of abortion-inducing drugs. Under the new provisions, a qualified physician must conduct an in-person examination of the patient before providing the drug, which includes verifying pregnancy, determining blood type, informing the patient of potential side effects, and documenting specific medical details in the patient's chart. Additionally, the physician must be credentialed to manage complications or have a signed agreement with another qualified physician. Follow-up appointments are mandated to confirm the termination of pregnancy and assess bleeding, with documentation of efforts to ensure patient compliance required in the medical record.

The bill also establishes a civil right of action for individuals who suffer from intentional or knowing violations of these requirements, allowing claims from the woman who received the drug, a minor's guardian, or the father of the unborn child under certain conditions. Relief for such actions includes monetary damages, statutory damages, and attorney fees. Furthermore, the bill emphasizes confidentiality for the identity of women involved in these cases and mandates pseudonym use for plaintiffs unless consent is given. Overall, the legislation aims to enhance patient safety and informed consent while reinforcing the legal framework surrounding abortion-inducing drugs.

Statutes affected:
Introduced Version: 36-2160
House Engrossed Version: 36-2160